TLA Targeted Immunotherapies AB
🇸🇪Sweden
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis
Not Applicable
Recruiting
- Conditions
- Ulcerative Colitis (UC)
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- TLA, Targeted Immunotherapies AB
- Target Recruit Count
- 12
- Registration Number
- NCT04550130
- Locations
- 🇸🇪
Ersta Sjukhus, Medicinkliniken, Stockholm, Sweden
News
No news found